
Alexander Kutikov MD, FACS
Associate Professor of Urologic Oncology, Fox Chase Cancer Center, Philadelphia, PennsylvaniaDr. Kutikov is a board certified, academic urologic surgical oncologist, who treats tumors of the adrenal, kidney, prostate, bladder, ureter, testis, and other genitourinary organs, using minimally invasive (robotic/laparoscopic) and traditional surgical techniques: https://www.foxchase.org/alexander-kutikov
Dr. Kutikov's current research interests include understanding renal/prostatic carcinogenesis, risk-stratification of surgical outcomes, and quantification of competing risks: http://www.fccc.edu/research/pid/kutikov/pub.html
Dr. Kutikov has significant interests in harnessing web and mobile technology to improve patient engagement and quality of care. He is a co-founder of VisibleHealth, Inc and UrologyMatch, LLC: http://www.visiblehealth.com
Recent Contributions to PracticeUpdate:
- Risk Factors for Peritoneal Carcinomatosis Following Open Radical Cystectomy
- Outcomes After Unilateral Adrenalectomy for Primary Aldosteronism
- Close Proximity to the Collecting System Increases Risk of Malignancy in Small Renal Tumors
- Incidence of Visible Hematuria Among Antithrombotic Agents
- Robot-Assisted Adrenalectomy vs Open Adrenalectomy
- Assessment of Cancer-Specific Mortality After Tumor Ablation vs Observation for Kidney Cancer
- A Nomogram for the Prediction of Indolent Renal Tumors
- Differentiation of Lipid-Poor Adrenal Adenomas From Non-Adenomas With Magnetic Resonance Imaging
- Pazopanib in Patients With Localized RCC to Optimize Preservation of Renal Parenchyma
- Presurgical Sunitinib Reduces Tumor Size and May Facilitate Partial Nephrectomy in Patients With Renal Cell Carcinoma